Evidence map›Paper›PMID 33860135›Full record

ReviewAnnals of gastroenterological surgery2021

Essential updates 2019/2020: Surgical treatment of gallbladder cancer.

Ryusei Matsuyama, Yasuhiro Yabusita, Yuki Homma, Takafumi Kumamoto, Itaru Endo

Open access · goldAbstract readReview
In one paragraph

Review in Annals of gastroenterological surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. The logarithmic phase as a therapeutic direction: evaluating pharmacological strategies against cancer progression.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Oncologic Extended Resection of T3-Stage Incidental Gallbladder Carcinoma.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2022
    Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ryusei MatsuyamaDepartment of Gastroenterological Surgery Yokohama City University Graduate School of Medicine Yokohama Japan.ORCID https://orcid.org/0000-0001-5131-0023
Yasuhiro YabusitaDepartment of Gastroenterological Surgery Yokohama City University Graduate School of Medicine Yokohama Japan.
Yuki HommaDepartment of Gastroenterological Surgery Yokohama City University Graduate School of Medicine Yokohama Japan.
Takafumi KumamotoDepartment of Gastroenterological Surgery Yokohama City University Graduate School of Medicine Yokohama Japan.
Itaru EndoDepartment of Gastroenterological Surgery Yokohama City University Graduate School of Medicine Yokohama Japan.ORCID https://orcid.org/0000-0001-5520-8114
Yokohama City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gallbladder cancer is a biliary tract cancer that originates in the gallbladder and cystic ducts and is recognized worldwide as a refractory cancer with early involvement of the surrounding area because of its anatomical characteristics. Although the number of cases is increasing steadily worldwide, the frequency of this disease remains low, making it difficult to plan large-scale clinical studies, and there is still much discussion about the indications for surgical resection and the introduction of multidisciplinary treatment. Articles published between 2019 and 2020 were reviewed, focusing mainly on the indications for surgical resection for each tumor stage, the treatment of incidental gallbladder cancer, and current trends in minimally invasive surgery for gallbladder cancer.

Indexed as

gallbladder cancerIGBCminimally invasive surgeryneoadjuvant chemotherapysurgical strategy

Identifiers

PMID33860135
PMCPMC8034687
OpenAlexW3129012525

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.